Pediatric Cancer
A diagnosis of cancer is devastating at any age, and treating the tumor with the lowest possibility of negative side effects is important at every age. But growing children face additional risks. For patients with pediatric cancer, therefore, Proton Therapy may be their best, most promising solution.

The accepted treatments for young cancer patients are surgery, traditional radiation or chemotherapy, either singly or in combination. Unfortunately, while these traditional treatments may successfully eradicate the tumor, they often leave damaging side effects for growing kids.  Among these side effects are hearing loss or damage to the salivary glands (when the tumor is located in the head or neck), developmental delays, and damage to bone and muscle tissue.

Since Proton Therapy is more precise and accurate than conventional radiation, it is especially advantageous when more sensitivity is required. The lesions and soft tissue tumors that are located near growing tissues in the brain, spinal cord, ears, eyes and mouth require extreme precision in treatment, so as not to negatively affect the different healthy growing tissues. With Proton Therapy, the beams are strictly controlled, carefully sparing the healthy tissues from excess radiation. If offers oncologists the possibility to propel high, potent doses of radiation directly to the child’s tumor site, increasing the chance of recovery exponentially.

The following are pediatric cancers which can be successfully treated with Proton Therapy:

  • Rhabdomyosarcomas
  • Non-rhabdo soft tissue sarcomas
  • Ewing's sarcoma
  • Medulloblastomas
  • Ependymoma
  • Germ cell tumors in the brain
  • Neuroblastoma
  • Retinoblastoma


At the New York Proton Therapy Institute, our physicians can tell you whether your child is a candidate for Proton Therapy.  Contact us with inquiries or to discuss your situation. Cancer isn’t child’s play. And NY Proton Therapy Institute wants to ensure that, indeed, it isn’t.

Copyright 2010 All Rights Reserved. Site Design: SmartWeb